A Cannabinoid 2-Selective Agonist Inhibits Allogeneic Skin Graft Rejection <i>In Vivo</i>.

A Cannabinoid 2-Selective Agonist Inhibits Allogeneic Skin Graft Rejection In Vivo.

Jayarajan, Senthil; Meissler, Joseph J; Adler, Martin W; Eisenstein, Toby K.

Afiliación

Jayarajan S; Center for Substance Abuse Research, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States.
Meissler JJ; Center for Substance Abuse Research, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States.
Adler MW; Center for Substance Abuse Research, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States.
Eisenstein TK; Center for Substance Abuse Research, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States.

Front Pharmacol ; 12: 804950, 2021.

Article en En | MEDLINE | ID: mdl-35185546